BioCentury
ARTICLE | Company News

Actavis, Purdue Pharma neurology news

October 27, 2014 7:00 AM UTC

Purdue Pharma filed suit in the U.S. District Court for the District of Delaware alleging that an ANDA submitted by Actavis for a generic version of Butrans buprenorphine infringes U.S. Patent Nos. R...